The purpose of this study was to investigate the expression of
IL-16 in the rheumatoid synovium and the role of inflammatory
cytokines and
Toll-like receptor (TLR)
ligands in
IL-16 production by fibroblast-like synoviocytes (FLS) of
rheumatoid arthritis (RA) patients. Immunohistochemical staining was performed with a
monoclonal antibody to
IL-16 in synovial tissues from patients with RA and likewise in patients with
osteoarthritis (OA). FLS were isolated from RA synovial tissues and stimulated with
IL-15, IL-1beta, IFN-gamma, and
IL-17. The
IL-16 mRNA level was assessed by semiquantitative RT-PCR and real time (RT) PCR and a comparison was made between
IL-16 mRNA levels produced by RA-FLS and OA-FLS. Production of
IL-16 was identified by a western blot assay, and
IL-16 production after stimulation by specific
ligands of TLR2 and TLR4 was assessed by RT-PCR. While immunohistochemical staining demonstrated strong expression of
IL-16 mRNA in synovial tissues from patients with RA, similar findings were not present in the OA group. Moreover,
mRNA expression of
IL-16 by RA-FLS increased
after treatment with
IL-17 but not with
IL-15, IL-1beta, and IFN-gamma. Specifically,
IL-17 increased
IL-16 mRNA level by RA-FLS and peripheral blood mononuclear cells in a dose-dependent manner. However,
IL-17 did not stimulate
IL-16 production in OA-FLS.
Peptidoglycan, a selective TLR2
ligand, also increased production of
IL-16 by RA-FLS dose- dependently, whereas LPS, a selective TLR4
ligand, had no such stimulatory effect. The results from our data demonstrate that
IL-17 and TLR2
ligands stimulate the production of
IL-16 by RA-FLS.